MannKind Corporation to Present at 8th Annual JMP Securities Healthcare Conference

  MannKind Corporation to Present at 8th Annual JMP Securities Healthcare
  Conference

Business Wire

VALENCIA, Calif. -- July 3, 2013

MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing and
commercializing treatments for diabetes, announced today that it will present
at the 8^th Annual JMP Securities Healthcare Conference on Wednesday, July 10,
2013 at 11:00 AM (ET) at The St. Regis Hotel in New York.

Interested parties can access a link to the live webcast of the presentations
from the News & Events section of the Company's website at
http://www.mannkindcorp.com.

About MannKind Corporation

MannKind Corporation (Nasdaq: MNKD) focuses on the discovery, development and
commercialization of therapeutic products for patients with diseases such as
diabetes. Its lead product candidate, AFREZZA®, is in late stage clinical
investigation for the treatment of adults with type 1 or type 2 diabetes for
the control of hyperglycemia. MannKind maintains a website at
www.mannkindcorp.com to which MannKind regularly posts copies of its press
releases as well as additional information about MannKind. Interested persons
can subscribe on the MannKind website to e-mail alerts that are sent
automatically when MannKind issues press releases, files its reports with the
Securities and Exchange Commission or posts certain other information to the
website.

Contact:

MannKind Corporation
Matthew J. Pfeffer
Corporate Vice President and
Chief Financial Officer
661-775-5300
mpfeffer@mannkindcorp.com
 
Press spacebar to pause and continue. Press esc to stop.